nnc0114-0006
Showing 1 - 5 of 5
Diabetes, Diabetes, Type 1 Trial in Worldwide (NNC0114-0006, liraglutide, )
Completed
- Diabetes
- Diabetes Mellitus, Type 1
- NNC0114-0006
- +2 more
-
La Jolla, California
- +107 more
Mar 10, 2021
Inflammation, Rheumatoid Arthritis Trial in Berlin, Moscow, Yaroslavl (NNC0114-0006, )
Completed
- Inflammation
- Rheumatoid Arthritis
- NNC0114-0006
- placebo
-
Berlin, Germany
- +4 more
Feb 6, 2017
Inflammation, Crohn's Disease Trial in Worldwide (NNC0114-0006, )
Completed
- Inflammation
- Crohn's Disease
- NNC0114-0006
- placebo
-
Tucson, Arizona
- +27 more
Mar 30, 2017
Inflammation, Rheumatoid Arthritis Trial in Worldwide (NNC0114-0006, )
Completed
- Inflammation
- Rheumatoid Arthritis
- NNC0114-0006
- placebo
-
Plovdiv, Bulgaria
- +32 more
Feb 6, 2017
Inflammation, Systemic Lupus Erythematosus Trial in Worldwide (NNC0114-0006, )
Terminated
- Inflammation
- Systemic Lupus Erythematosus
- NNC0114-0006
- placebo
-
La Jolla, California
- +4 more
Apr 7, 2014